This work may not be copied, distributed, displayed, published, reproduced, transmitted, modified, posted, sold, licensed, or used for commercial purposes. By downloading this file, you are agreeing to the publisher’s Terms & Conditions.


An Update on the Future of Wilson Disease Management

Robert S. Brown, Jr, MD, MPHa

Published: November 29, 2022


The recognition of Wilson disease (WD) has progressed over the last century from a neurologic disorder associated with liver disease to the understanding that WD is a rare autosomal recessive genetic disorder of copper metabolism. Due to WD’s myriad manifestations, its rarity, and its broad range of symptoms, differential diagnosis may be challenging, leading to delays in treatment initiation. This Neuroscience Commentary reviews diagnostic acumen and the latest updates in the field, including key clinical data and novel therapies in late-stage development, all of which ensure optimal management of WD in the coming years.

PDF version of article
Note: To receive credit, you must navigate through the entire online activity. Click link below.


To cite: Brown RS Jr. An update on the future of Wilson disease management. Prim Care Companion CNS Disord. 2022;24(6):AN21065COM1C.
To share:
© Copyright 2022 Physicians Postgraduate Press, Inc.

aWeill Cornell Medicine, New York, New York

Volume: 24

Quick Links: